Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
MDMA-assisted Massed Prolonged Exposure for PTSD
Healing Breakthrough
Early Effects of Ketamine vs Placebo With Venlafaxine in Severe Depression Patients
Assistance Publique - Hôpitaux de Paris
Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers
Robin Carhart-Harris, PhD, MA
Open-Label Psilocybin Study in Transdiagnostic Population
Yale University
Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting
Theresa Jacob, PhD, MPH
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression
University Health Network, Toronto
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Small Tonsils
Oregon Health and Science University
The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD
Margaux M. Salas, PhD
At-Home tDCS as Maintenance Therapy
Technical University of Munich
Psilocybin in Cancer Pain Study
Yvan Beaussant, MD, MSci
(2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic Pain
Rush University Medical Center
Ketamine for Methamphetamine Use Disorder
University of Texas Southwestern Medical Center
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
Sharmin Ghaznavi
Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD
Centre for Addiction and Mental Health
Imaging Depression in Parkinson's Disease
Yale University
The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Dr. Inge Winter
Psilocybin Therapy for Depression in Parkinson's Disease
Joshua Woolley, MD, PhD
Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects
GH Research Ireland Limited
The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)
4th Military Clinical Hospital with Polyclinic, Poland
Low-Dose Ketamine Infusion During Burn Wound Care
University of Tennessee
Lysergic Acid Diethylamide (LSD) in Palliative Care
University Hospital, Basel, Switzerland
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
University of Rochester
Psilocybin for Hospitalized Patients with Treatment-resistant Depression
University Hospital, Ghent
Belief Updating in Treatment Resistant Depression
Assistance Publique - Hôpitaux de Paris
The Impact of Psilocybin on Pain in Fibromyalgia Patients
Maastricht University
Nebulized Ketamine to Nebulized Fentanyl for Treating Acute Painful Conditions in the ED
Antonios Likourezos
Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
Lindsay Maguire, MD
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
Melt Pharmaceuticals
Pharmacologic Treatment Augmentation in Chronic Depression
University Hospital Tuebingen
Psilocybin in Chronic Low Back Pain and Depression
Johns Hopkins University
Psilocybin-Assisted Therapy in Treatment-Resistant Depression
University of North Carolina, Chapel Hill
Cancer Related Major Depression Treated With a Single Dose of Psilocybin
Section for Affective Disorders; Northern Stockholm Psychiatry
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
M.D. Anderson Cancer Center
MDMA for Co-occurring PTSD and OUD After Childbirth
University of New Mexico
Non-steroidal Anti-inflammatory in Cardiac Surgery
Centre Hospitalier Universitaire, Amiens
Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
University of Calgary
Opioid-free Anesthesia as an Alternative to General Anesthesia in Abdominal Surgery
Jagiellonian University
Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain
University of California, Berkeley
Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study
Reinier de Graaf Groep
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
Stanford University
Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder
Brugmann University Hospital
Psilocybin in Functional Neurological Disorder
King's College London
Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
Johns Hopkins University
MDMA for AUD/PTSD Comorbidity
Carolina L Haass-Koffler
Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin
University Health Network, Toronto
Ketamine and Neurofeedback-Training: Effects on Neuroplasticity in Cocaine Addiction
Dr. med. Marcus Herdener
Neural Circuit Effects of Ketamine in Depression
Icahn School of Medicine at Mount Sinai
The OBSERVE Protocol
Yale University
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.